β-Protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients

Acta Neuropathologica

Volumn 111, Issue 2, 2006, Pages 126-138

  van de Nes, Johannes A P ^a   Konermann, S ^a   Nafe, R ^b   Swaab, D F ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Alzheimer's disease; Amyloid; Human hypothalamus; Hyperphosphorylated tau; Nucleus tuberalis lateralis; Somatostatin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; MONOCLONAL ANTIBODY; NEUROPEPTIDE; POLYCLONAL ANTIBODY; SOMATOSTATIN ANTIBODY; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL DENSITY; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; MALE; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SILVER STAINING; SOMATOSTATIN CELL;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIBODIES, MONOCLONAL; COLORING AGENTS; CONGO RED; HUMANS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEURONS; PHOSPHORYLATION; SILVER STAINING; SOMATOSTATIN; STAINING AND LABELING; TAU PROTEINS;

EID: 33646178141     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-005-0018-8     Document Type: Article

References (60)

1. Adlard PA, Perreau VM, Pop V, Cotman CW (2005) Voluntary exercise decreases amyloid load in a transgenic mice model of Alzheimer's disease. J Neurosci 25:5217-4221
2. Axelson JF, Van Leeuwen FW (1990) Differential localization of estrogen receptors in various vasopressing synthesizing nuclei of the rat brain. J Neuroendocrinol 2:209-216
3. Benoit R, Ling N, Alford B, Guillemin R (1982) Seven peptides derived form pro-somatostatin in the rat brain. Biochem Biophys Res Commun 107:944-950
4. 1-12) -like peptides. In: Patel YC, Tannenbaum GS (eds) Somatostatin. Plenum Press, New York, NY, pp 89-107
5. Benzing WC, Brady DR, Mufson EJ, Armstrong DM (1993) Evidence that transmitter-containing dystrophic neurites precede those containing paired helical filaments within senile plaques in the entorhinal cortex of nondemented elderly and Alzheimer's disease patients. Brain Res 619:55-68
6. Bouras C, Magistretti PJ, Morrison JH, Constantidinis J (1987) An immunohistochemical study of pro-somatostatin-derived peptides in the human brain. Neuroscience 22:781-800
7. Braak H, Braak E (1991) Neuropathologic stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
8. Braak E, Braak H, Mandelkow E-M (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554-567
9. Braak H, Braak E (1998) Argyrophilic grain disease: Frequency of occurrence in different categories and neuropathological diagnositic criteria. J Neural Transm 105:801-819
10. Busciglio J, Lorenzo A, Yeh J, Yankner BA (1995) β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879-888
11. Chambers CB, Sigurdsson EM, Hejna MJ, Lorens SA, Lee JM, Muma NA (2000) Amyloid-β injection in rat amygdala alters tau protein but not mRNA expression. Exp Neurol 162:158-170
12. Chan-Palay V (1986) Somatostatin immunoreactive neurons in the hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects of Alzheimer disease. J Comp Neurol 260:201-223
13. 4.) Anat Rec 190:369-370 (abstract)
14. Ferreira A, Lu Q, Orecchio L, Kosik KS (1997) Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar Aβ. Mol Cell Neurosci 9:93-96
15. Gallyas F (1971) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 19:1-8
16. Games D, Adams D, Allessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConiugue I, Mantoya-Zavaia M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527
17. Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, Yankner BA (1998) Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat Med 4:827-831
18. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylation at both serine 202 and threonine 205. Neurosci Lett 189:167-170
19. Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science 293:1491-1495
20. Hayes TL, Cameron JL, Fernstrom JD, Lewis DA (1990) A comparative analysis of the distribution of pro-somatostatin-derived peptides in monkey and human neocortex. J Comp Neurol 303:584-599
21. Hirano A, Zimmermann HM (1962) Alzheimer's neurofibrillary changes: A topographical study. Arch Neurol 7:227-242
22. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 274:99-102
23. Ishii T (1966) Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol 6:181-187
24. Katsuno T, Morishima-Kawashima M, Saito Y, Yamanouchi H, Ishiura S, Murayama S, Ihara Y (2005) Independent accumulations of tau and amyloid β-protein in the human entorhinal cortex. Neurologist 64:687-692
25. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230-236
26. Koutcherov Y, Mai JK, Ashwell KWS, Paxinos G (2002) Organisation of human hypothalamus in fetal development. J Comp Neurol 423:299-318
27. Kremer HPH, Roos RAC, Dingjan G, Marani E, Bots GThAM (1990) Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J Neuropathol Exp Neurol 49:371-382
28. Kremer HPH, Swaab DF, Bots GThAM, Fisser B, Ravid R, Roos RAC (1991) The hypothalamic lateral tuberal nucleus in Alzheimer's disease. Ann Neurol 29:279-284
29. Kremer HPH (1992) The hypothalamic lateral tuberal nucleus: Normal anatomy and changes in neurological diseases. Prog Brain Res 93:249-261
30. Lazarov O, Robinson J, Tang Y-P, Hairston IS, Korade-Mirnics Z, Lee VM-Y, Hersh LB, Sapolsky RB, Mirnics K, Sisodia SS (2005) Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice. Cell 120:701-713
31. Lee H-G, Casadesus G, Zhu X, Joseph JA, Perry G, Smith MA (2004) Perspectives on the amyloid-β cascade hypothesis. J Alzheimers Dis 6:137-145
32. Lee H-G, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, Takeda A, Nunomora A, Smith MA (2005) Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol Med 11:164-169
33. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, Frosch MP, Selkoe DJ (2003) Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40:1087-1093
34. Lenders M-B, Peers M-C, Tramu G, Delacourte A, Defossez A, Petit H, Mazzuca M (1989) Dystrophic peptidergic neurites in senile plaques of Alzheimer's disease hippocampus precede formation of paired helical filaments. Brain Res 481:344-349
35. Lewis J, Dickson DW, Lin W-L, Chisholm L, Corral A, Jones G, Yenn S-H, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487-1491
36. Liu R-Y, Zhou J-N, Hoogedijk WJG, van Heerikhuize J, Kamphorst W, Ummehopa UA, Hofman MA, Swaab DF (2000) Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol 59:314-332
37. Mengod G, Rigo M, Savasta M, Probst A, Palacios JM (1992) Regional distribution of neuropeptide somatostatin gene expression in the human brain, Synapse 12:62-74
38. Mercken M, Vandermeeren M, Lubke U, Six J, Boons J, Van de Voorde A, Martin J-J, Gheuens J (1992) Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84:265-272
39. Morrison JH, Benoit R, Magistretti PJ, Bloom FE (1983) Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex. Brain Res 262:344-351
40. Mufson EJ, Benoit R, Mesulam MM (1988) Immunohistochemical evidence for a possible somatostatin-containing amygdalostriatal pathway in normal and Alzheimer's disease brain. Brain Res 453:117-128
41. Najimi M, Chigr F, Leduque P, Jordan D, Charnay Y, Chayville JA, Tohyama M, Kopp N (1989) Immunohistochemical distribution of somatostatin in the infant hypothalamus. Brain Res 483:205-220
42. Najimi M, Jordan D, Chigr F, Champier J, Kopp N, Slama A, Bertherat J, Videau C, Epelbaum J (1991) Regional distribution of somatostatin binding sites in the human hypothalamus: A quantitative autoradiographic study. Neuroscience 40:321-335
43. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaque and tangles: Intracellular Aβ deposits and synaptic dysfunction. Neuron 39:409-421
44. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic mice model of Alzheimer's disease. Neurobiol Aging 24:1063-1070
45. Reubi JC, Cortes R, Maurer R, Probst A, Palacios JM (1986) Distribution of somatostatin receptors in the human brain; an autoradiographic study. Neuroscience 18:329-346
46. Romijn HJ, Van Uum JF, Emmering J, Goncharuk V, Buijs RM (1999) Colocalization of VIP with AVP in neurons of the human paraventricular, supraoptic and suprachiasmatic nucleus. Brain Res 832:47-53
47. Rudelli RD, Ambler MW, Wisniewski HM (1984) Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol 64:273-281
48. Salehi A, Van de Nes JAP, Hofman MA, Gonatas NK, Swaab DF (1995) Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity. Brain Res 578:29-39
49. Saper CB, German DC (1987) Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 74:364-370
50. Saper CB (1990) Hypothalamus. In: Paxinos G (ed) The human nervous system. Academic, San Diego, CA, pp 389-413
51. Schultz C, Koppers D, Sassin I, Braak E, Braak H (1998) Cytoskeletal alterations in the human tuberal hypothalamus related to argyrophilic grain disease. Acta Neuropathol 96:596-602
52. Schultz C, Ghebremedhin E, Braak E, Braak H (1999) Sex-dependent cytoskeletal changes of the human hypothalamus develop independently of Alzheimer's disease. Exp Neurol 160:186-193
53. Standaert DG, Lee VM-Y, Greenberg BD, Lowery DE, Trojanowski JQ (1991) Molecular features of hypothalamic plaques in Alzheimer's disease. Am J Pathol 139:681-691
54. Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, Satlin A (1999) Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 58:29-39
55. Swaab DF (2003) Lateral tuberal nucleus. In: Aminoff MJ, Boller F, Swaab DF (eds) Handbook of clinical Neurology, vol 79, The human hypothalamus: basic and clinical aspects, Part 1: Nuclei of the hypothalamus. Elsevier, Amsterdam, pp 263-268
56. Timmers HJLM, Swaab DF, Van de Nes JAP, Kremer HPH (1996) Somatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington's disease patients. Brain Res 728:141-148
57. Van de Nes JAP, Kamphorst W, Ravid R, Swaab DF (1993) The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients. Brain 116:103-115
58. Van de Nes JAP, Sluiter AA, Pool CW, Kamphorst W, Ravid R, Swaab DF (1994) The monoclonal antibody Alz-50, used to reveal cytoskeletal changes in Alzheimer's disease, also reacts with a large subpopulation of somatostatin neurons in the human hypothalamus and adjoining areas. Brain Res 655:97-109
59. Van de Nes JAP, Kamphorst W, Ravid R, Swaab DF (1998) Comparison of β-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol 96:129-138
60. Van de Nes JAP, Sandmann-Keil D, Braak H (2002) Interstitial cells in the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to develop Alzheimer's disease-related cytoskeletal changes. Acta Neuropathol 104:351-356